| Product Name | CHEM ELISA kit (Human) |
|---|---|
| Description | This assay has high sensitivity and excellent specificity for detection of Chemerin (CHEM). No significant cross-reactivity or interference between Chemerin (CHEM) and analogues was observed. |
| Synonyms | TIG2; RARRES2; Tazarotene-Induced Gene 2; Retinoic Acid Receptor Responder 2,Tazarotene Induced; RAR-responsive protein TIG2 |
| Method | Sandwich |
| Detection Range | 0.156-10ng/mL |
| Sensitivity | 0.059ng/mL |
| Target | CHEM |
| Specificity | This assay has high sensitivity and excellent specificity for detection of Chemerin (CHEM). No significant cross-reactivity or interference between Chemerin (CHEM) and analogues was observed. |
| Reactivity | Human |
| Sample Types | Serum, Plasma, Tissue Homogenates, Cell Lysates, Cell Culture Supernates And Other Biological Fluids |
| Reconstitution | 1.Prepare all reagents, samples and standards; 2.Add 100uL standard or sample to each well.Incubate 2 hours at 37℃; 3.Aspirate and add 100uL prepared Detection Reagent A.Incubate 1 hour at 37℃; 4.Aspirate and wash 3 times; 5.Add 100uL prepared Detection Reagent B.Incubate 30 minutes at 37℃; 6.Aspirate and wash 5 times; 7.Add 90uL Substrate Solution.Incubate 10-20 minutes at 37℃; 8.Add 50uL Stop Solution.Read at 450nm immediately. |
| Uniprot | Q99969 |
| Storage | 4°C for 1 month/ -20°C for long-term(within shelf life) |
| Notes | Colormetric |
| References | Serum chemerin and vaspin in non-alcoholic fatty liver disease;Chemerin, vaspin and insulin resistance in chronic hepatitis C;Chronic ethanol consumption increases the levels of chemerin in the serum and adipose tissue of humans and rats;Ankilozan spondilitli hastalarda adipositokin düzeyleri ve insülin direnci;Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients;Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects;Impact of OSA on Biological Markers in Morbid Obesity and Metabolic Syndrome;Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia;Relationship between plasma chemerin levels and disease severity in COPD patients;Elevated serum chemerin in Chinese women with hyperandrogenic PCOS;Chemerin and calprotectin levels correlate with disease activity and inflammation markers in psoriasis vulgaris;Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study;Association of Serum Chemerin Levels with Acute Ischemic Stroke and Carotid Artery Atherosclerosis in a Chinese Population;Association of chemerin levels and bone mineral density in Chinese obese postmenopausalwomen.;Chemerin is associated with diabetic retinopathy in type 2 diabetes;Expression of chemerin in the synovial fluid of patients with temporomandibular joint disorders;Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer;Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men;Plasma levels of adiponectin and chemerin are associated with early stage of atherosclerosis in older adults with type 2 diabetes mellitus;The dietary inflammatory index is associated with anti-and pro-inflammatory adipokines in Brazilian schoolchildren;Pro-and anti-inflammatory adipokines are associated with cardiometabolic risk markers in Brazilian schoolchildren;Altered Serum Marker of Adipokines Profile in Breast Cancer Women;Association of High Serum Chemerin with Bone Mineral Density Loss and Osteoporotic Fracture in Elderly Chinese Women; |
| Supplier | Cloud Clone |
PROTOCOLS:
SEA945Hu All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
